期刊文献+

肿瘤坏死因子相关的凋亡诱导配体(TRAIL)cDNA的克隆、表达和活性测定 被引量:7

Cloning, Expression and Bioactivity of TNF-related Apoptosis Inducing Ligand(TRAIL)
下载PDF
导出
摘要 肿瘤坏死因子相关的凋亡诱导配体 (TRAIL)能选择性诱导肿瘤细胞凋亡 .为利用基因工程技术获得重组TRAIL蛋白可溶性片段 (sTRAIL) ,设计 1对引物 .利用PCR技术特异性扩增出sTRAIL的cDNA ,克隆于质粒pGEM 3Zf( )的EcoRⅠ和PstⅠ位点 .经测序证明序列正确后克隆于表达质粒pBV2 2 0的EcoRⅠ和PstⅠ位点 ,转化大肠杆菌DH5α .转化菌株经温度诱导 ,SDS PAGE检测和Western印迹鉴定 ,获得重组sTRAIL的高水平非融合表达菌株 .表达量占菌体总蛋白的 2 0 % .对其表达产物进行了初步纯化 ,SDS PAGE结果显示纯度可达 90 %以上 .用L92 9细胞测定其生物学活性表明 。 TNF related apoptosis inducing ligand(TRAIL) can induce specific apoptosis of cancer cells. In order to obtain recombinant TRAIL through genetic engineering, the cDNA coding soluble fragment of TRAIL(sTRAIL) was amplified from human placental cDNA library by PCR method and cloned into pGEM 3Zf(-) vector to analyze the sequence. The result showed that DNA sequence of cloned human sTRAIL was the same as that reported previously. To express sTRAIL,the cDNA was cloned into expression vector pBV220 which was then transformed into E.coli DH5α host bacteria. The recombinant protein was expressed with the yield of 20% total bacterial protein. SDS PAGE and Western blot analysis indicated that the molecular weight of recombinant protein was about 18 5 kD and could react specifically with anti TRAIL monoantibody. The recombinant protein was purified and could significantly induce apoptosis of L929 cells.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2002年第1期27-31,共5页 Chinese Journal of Biochemistry and Molecular Biology
关键词 TRAIL 克隆 表达 诱导凋亡配体 TNF 肿瘤坏死因子 活性测定 TRAIL, cloning, expression, apoptosis inducing
  • 相关文献

参考文献1

二级参考文献3

  • 1余为明 焦炳华.肿瘤坏死因子及其相关毒素[M].上海:上海科学技术出版社,1991..
  • 2Pan G,Science,1997年,277卷,815页
  • 3余伟明,肿瘤坏死因子及相关细胞毒素,1991年

共引文献8

同被引文献56

  • 1周建,彭旭东,张健,高小平.重组人TRAIL蛋白的原核表达、纯化及鉴定[J].四川大学学报(自然科学版),2002,39(S1):142-145. 被引量:3
  • 2戴丹菁,谢丛华,张阿丽,邱慧兵,周遵艳.TRAIL联合放射线诱导人脑胶质瘤细胞株U251凋亡的协同作用研究[J].武汉大学学报(医学版),2006,27(6):759-762. 被引量:5
  • 3Ashkenaz A. Directing cancer cells to self-destruct with pro- apoptotic receptor agonists [ J]. Nat Rev Drug Discov, 2008,7 (12) :1001-1012.
  • 4Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induce apoptosis[ J]. Immunity, 1995,3 (6) :6673-682.
  • 5Nagata S. Apoptosis by death factor[J]. Ce11,1997,88(3) :355-365.
  • 6Griffith TS, Stokes B, Kucaba TA, et al. TRAIL gene therapy: From preclinical development to clinical application [ J ]. Curr Gene Ther,2009,9( 1 ) :9 -19.
  • 7Keane MM, Ettenherg SA, Nau MM, et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines [ J ]. Cance Res, 1999,59 (3) :734-741.
  • 8Kruyt F A. TRAIL and cancer therapy[ J]. Cancer Lett,2008,263 (1) :14-25.
  • 9Dohmen R J. SUMO protein modification [ J ]. Biochim Biophys Acta,2004,1695 ( 1-3 ) : 113-131.
  • 10Marblestone JG, Edavettal SC, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO [ J]. Protein Sci, 2006,15( 1 ) :182-189.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部